摘要
目的探讨细胞粘附分子CD44、细胞增值核抗原Ki-67在侵袭性垂体腺瘤中的表达及意义并探讨二者之间的关系。方法用免疫组化法检测CD44s、CD44v5、Ki-67在20例侵袭性垂体腺瘤和18例非侵袭性垂体腺瘤中的表达。结果CD44s和Ki-67在侵袭性垂体腺瘤组中表达高于非侵袭性垂体腺瘤组(P<0.01),且二者在垂体腺瘤中的表达呈正相关。CD44v5在侵袭性和非侵袭性垂体腺瘤中表达无明显差异(P>0.05)。结论CD44s和Ki-67与垂体腺瘤的侵袭性生长行为有关,二者协同作用,在侵袭性垂体腺瘤的发生、发展中起重要作用,可作为侵袭性垂体腺瘤诊断和判断预后的重要生物学指标。
Objective To study the expression and role of CD44 and Ki-67 in invasive pituitary adenoma and the relationship between them. Methods The expression of CD44s,CD44v5 and Ki-67 in 20 cases invasive pituitary adenoma and 18 cases non-invasive pituitary adenoma were detected with SP immunohistochemical technique. Results The expressive levels of CD44s and Ki-67 in the invasive pituitary adenomas were significantly higher than those in the non-invasive ones (P〈0. 01 ), it is positively correlation between them. The expression levels of CD44v5 in the invasive and non-invasive pituitary adenomas has no difference. Conclusion CD44s and Ki-67 correlated with invasiveness of pituitary adenoma, they cooperated and play a important role in occurrence and progression of pituitary adenoma. They may be an objective biological marker for diagnose and estimating prognosis of invasive pituitary adenoma.
出处
《肿瘤防治研究》
CAS
CSCD
北大核心
2006年第7期490-492,F0003,共4页
Cancer Research on Prevention and Treatment